UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Microsoft Outage Causing Global Disruption To Services
One Killed And Four Injured In Washington DC Shooting
Nvidia Boss Resigns After Reports Of Two Affairs, One Allegedly With A Chinese Spy
Ukraine And Russia Agree Large-Scale Exchange Of Prisoners Following Talks
Russell Brand Sentenced To 10.5 Years In Prison For Rape, Sexual Assault
French Prime Minister Claims Aer Lingus Pilots Initially Refused To Land In France After Bomb Threat
Russell Brand Found Guilty of Rape and Three Counts of Sexual Assault
US Vice President Blames Iran War For Republican Collapse